At a glance
- Originator Johnson & Johnson Pharmaceutical Research & Development
- Developer Johnson & Johnson Pharmaceutical Research & Development LLC
- Class Analgesics; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Alpha 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 05 Oct 2001 No-Development-Reported for Pain in USA (Unknown route)
- 11 May 1999 New profile
- 11 May 1999 Preclinical development for Pain in USA (Unknown route)